EDIZIONI MINERVA MEDICA S.p.A.

Dear Doctor,

You may be interested in reading the recently published issue

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3)


ELECTRONIC TABLE OF CONTENTS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):221-4
Neuroimaging in patients with high-grade gliomas
Norbert GALLDIKS *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):225-38
Overview on current treatment standards in high-grade gliomas
Alessia PELLERINO *, Federica FRANCHINO, Riccardo SOFFIETTI, Roberta RUDÀ

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):239-53
Conventional and advanced magnetic resonance imaging in patients with high-grade glioma
Whitney B. POPE *, Garth BRANDAL

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):254-66
Role of amino-acid PET in high-grade gliomas: limitations and perspectives
Antoine VERGER *, Javier ARBIZU, Ian LAW

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):267-71
The role of amino-acid PET in the light of the new WHO classification 2016 for brain tumors
Bogdana SUCHORSKA *, Nathalie L. ALBERT, Elena K. BAUER, Jörg-Christian TONN, Norbert GALLDIKS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):272-80
Radiomics derived from amino-acid PET and conventional MRI in patients with high-grade gliomas
Philipp LOHMANN *, Martin KOCHER, Jan STEGER, Norbert GALLDIKS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):281-94
Investigational PET tracers for high-grade gliomas
Gagandeep CHOUDHARY, Karl-Josef LANGEN, Norbert GALLDIKS, Jonathan McCONATHY *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):295-302
Functional magnetic resonance imaging in glioma patients: from clinical applications to future perspectives
Lukas J. VOLZ *, Martin KOCHER, Philipp LOHMANN, Nadim J. SHAH, Gereon R. FINK, Norbert GALLDIKS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):303-12
Half-time bone scintigraphy in prostate and breast cancer patients
Willem GROOTJANS *, Sara J. SERÉM, Monique I. GOMES, Linda HEIJMEN, Ben F. BULTEN, Eddy P. MIJNHEERE, Rick HERMSEN, Wim J. van den BROEK

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):313-20
Evaluation of predictor variables of diagnostic  FDG-PET/CT in fever of unknown origin
Kursat OKUYUCU, Engin ALAGOZ, Seref DEMİRBAS, Semra INCE *, Ahmet KARAKAS, Ozgur KARACALİOGLU, Bengul GUNALP, Nuri ARSLAN

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):321-4
Clinical value of quantitative measurements derived from GATED SPECT: motion and thickening, volumes and related LVEF
Walter NOORDZIJ *, Riemer H. SLART

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):325-35
Reversible myocardial perfusion defects in patients not suffering from obstructive epicardial coronary artery disease as assessed by coronary angiography
Christophe van de WIELE *, Adriana RIMBU, Tarik BELHOCINE, Bart de SPIEGELEER, Mike SATHEKGE, Alex MAES


Sincerely,
Edizioni Minerva Medica